Drug Pipeline

[68Ga]Ga-DOTA-TATE Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
0
Recruiting
1
Top Sponsors
Active Studies by Phase
Phase 1/2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT05142696 A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With… Extensive Stage Small Cell Lung Cancer Active, Not Recruiting
Phase 1
NCT05109728 A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in… Glioblastoma Active, Not Recruiting
NCT06379217 NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted… Metastatic Neuroendocrine Prostate Cancer Active, Not Recruiting
Sponsors Running [68Ga]Ga-DOTA-TATE Trials
Novartis Pharmaceuticals (3)
Disease Areas
Glioblastoma (1) Small Cell Lung Cancer (1) Lung Cancer (1) Prostate Cancer (1)
Get alerts when [68Ga]Ga-DOTA-TATE trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free